Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Energy-releasing Steps of Glycolysis01:28

Energy-releasing Steps of Glycolysis

146.5K
Glycolysis is divided into two phases based on whether energy is utilized or released. While the first phase consumes ATP, the second phase produces energy in the form of ATP and NADH. The energy is released over a sequence of reactions that turns G3P into pyruvate. The energy-releasing phase—steps 6-10 of glycolysis—occurs twice, once for each of the two 3-carbon sugars produced during steps 1-5 of the first phase.
The first energy-releasing step—the 6th step of glycolysis...
146.5K
Responses to Gravity and Touch02:26

Responses to Gravity and Touch

41.7K
Gravitropism: Plant Responses to Gravity
41.7K
Responses to Drought and Flooding02:41

Responses to Drought and Flooding

12.0K
Water plays a significant role in the life cycle of plants. However, insufficient or excess of water can be detrimental and pose a serious threat to plants.
12.0K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.6K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.6K
ATP Energy Storage and Release01:31

ATP Energy Storage and Release

14.1K
ATP is a highly unstable molecule. Unless quickly used to perform work, ATP spontaneously dissociates into ADP and inorganic phosphate (Pi), and the free energy released during this process is lost as heat. The energy released by ATP hydrolysis is used to perform work inside the cell and depends on a strategy called energy coupling. Cells couple the exergonic reaction of ATP hydrolysis with endergonic reactions, allowing them to proceed.
One example of energy coupling using ATP involves a...
14.1K
Humoral Immune Responses01:36

Humoral Immune Responses

83.5K
Overview
83.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Harnessing pre-existing measles immunity: mRNA-Lipid nanoparticle-mediated measles hemagglutinin expression boosts antitumor CD8⁺ T cell responses.

Signal transduction and targeted therapy·2026
Same author

Smartphone-assisted lateral flow nanosensor for the selective detection of GHB in urine.

Biosensors & bioelectronics·2026
Same author

A Renal Clearable Probe for In Vivo Monoamine Oxidase (MAO) Detection.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Folate- and aCD47-functionalized lipid nanoparticles efficiently deliver mRNA and remodel pancreatic tumor microenvironment.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Bi-Functional Topospecific Nanoparticles to Promote Immune-Tumor Cell Engagement as A New Immunotherapeutic Strategy.

Advanced materials (Deerfield Beach, Fla.)·2025
Same author

Bioorthogonal Photoactivation of 2-Nitrobenzyl Caged Doxorubicin Anticancer Prodrugs on Gold Nanostars.

Advanced materials (Deerfield Beach, Fla.)·2025

Related Experiment Video

Updated: Jan 25, 2026

Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System
04:55

Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System

Published on: November 22, 2016

7.1K

Acetylcholine-responsive cargo release using acetylcholinesterase-capped nanomaterials.

Tania M Godoy-Reyes1, Antoni Llopis-Lorente, Alba García-Fernández

  • 1Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat Politécnica de Valencia, Universitat de València, Spain.

Chemical Communications (Cambridge, England)
|May 2, 2019
PubMed
Summary

Mesoporous silica nanoparticles functionalized with acetylcholinesterase selectively release their cargo upon encountering acetylcholine. This targeted drug delivery system offers precise control over cargo release triggered by specific biological cues.

More Related Videos

Biofunctionalization of Magnetic Nanomaterials
06:40

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

3.0K
Harnessing the Power of MicroRNA Cargoes in Small Extracellular Vesicles Released from Fresh-Frozen Human Brain Sections
07:55

Harnessing the Power of MicroRNA Cargoes in Small Extracellular Vesicles Released from Fresh-Frozen Human Brain Sections

Published on: November 8, 2024

843

Related Experiment Videos

Last Updated: Jan 25, 2026

Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System
04:55

Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System

Published on: November 22, 2016

7.1K
Biofunctionalization of Magnetic Nanomaterials
06:40

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

3.0K
Harnessing the Power of MicroRNA Cargoes in Small Extracellular Vesicles Released from Fresh-Frozen Human Brain Sections
07:55

Harnessing the Power of MicroRNA Cargoes in Small Extracellular Vesicles Released from Fresh-Frozen Human Brain Sections

Published on: November 8, 2024

843

Area of Science:

  • Nanotechnology
  • Biochemistry
  • Materials Science

Background:

  • Mesoporous silica nanoparticles (MSNs) are widely investigated for drug delivery due to their high surface area and tunable pore size.
  • Controlled cargo release remains a significant challenge in nanomedicine, necessitating stimuli-responsive systems.
  • Acetylcholinesterase (AChE) is a crucial enzyme in neurotransmission, making it a potential target for localized biological triggers.

Purpose of the Study:

  • To develop a novel nanocarrier system for selective cargo release.
  • To engineer MSNs that respond specifically to the presence of acetylcholine.
  • To utilize the enzymatic activity of acetylcholinesterase for triggered release applications.

Main Methods:

  • Synthesized mesoporous silica nanoparticles.
  • Functionalized nanoparticle surfaces with acetylcholinesterase via boronic ester linkages.
  • Investigated cargo release kinetics in the presence and absence of acetylcholine.
  • Characterized nanoparticle stability and enzyme activity.

Main Results:

  • The developed nanoparticles demonstrated selective cargo release exclusively in the presence of acetylcholine.
  • Boronic ester linkages provided a stable yet cleavable connection for enzyme immobilization.
  • The system showed efficient loading and triggered release of model drug cargo.
  • Enzyme activity remained largely intact after conjugation to the nanoparticles.

Conclusions:

  • Mesoporous silica nanoparticles capped with acetylcholinesterase offer a promising platform for targeted and stimuli-responsive drug delivery.
  • The acetylcholine-triggered release mechanism provides a high degree of selectivity for potential therapeutic applications.
  • This approach represents a significant advancement in designing intelligent nanocarriers for precise biological intervention.